Ligand validation:6JLK

PHO: PHEOPHYTIN A

PHO is a Ligand Of Interest in 6JLK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLK_PHO_a_411	76%	16%	0.136	0.972	1.88	1.78	9	10	0	0	100%	1
6JLK_PHO_A_408	75%	19%	0.129	0.961	1.83	1.6	8	7	0	0	100%	1
6JLK_PHO_a_418	71%	15%	0.14	0.96	1.81	1.98	8	8	0	0	100%	0.4
6JLK_PHO_A_409	70%	16%	0.144	0.961	1.88	1.8	8	9	0	0	100%	0.4
5V2C_PHO_A_608	98%	28%	0.059	0.979	1.52	1.37	8	7	0	0	100%	1
5B66_PHO_A_403	96%	27%	0.068	0.978	1.34	1.59	6	8	0	0	100%	1
8IRF_PHO_a_407	95%	16%	0.075	0.98	1.83	1.87	8	9	0	0	100%	0.49
8IRI_PHO_a_408	95%	16%	0.076	0.981	1.83	1.87	8	9	0	0	100%	0.49
8IR8_PHO_A_407	95%	18%	0.076	0.98	1.78	1.77	8	11	0	0	100%	0.4
7YQ7_PHO_A_407	96%	20%	0.069	0.979	1.7	1.65	7	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.